• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

点突变检测方法:性能与质量评估。国际临床化学和检验医学联合会科学部,分子生物学技术委员会。

Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques.

作者信息

Nollau P, Wagener C

机构信息

Department of Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany.

出版信息

Clin Chem. 1997 Jul;43(7):1114-28.

PMID:9216447
Abstract

We give an overview of current methods for the detection of point mutations as well as small insertions and deletions in clinical diagnostics. For each method, the following characteristics are specified: (a) principle, (b) major modifications, (c) maximum fragment size that can be analyzed, (d) ratio and type of mutations that can be detected, (e) minimum ratio of mutant to wild-type alleles at which mutations can be detected, and (f) detection methods. Special attention is paid to the possibilities of quality assessment and the potential for standardization and automation.

摘要

我们概述了临床诊断中检测点突变以及小插入和缺失的当前方法。对于每种方法,规定了以下特征:(a) 原理,(b) 主要改进,(c) 可分析的最大片段大小,(d) 可检测的突变比例和类型,(e) 可检测突变的突变型与野生型等位基因的最小比例,以及 (f) 检测方法。特别关注质量评估的可能性以及标准化和自动化的潜力。

相似文献

1
Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques.点突变检测方法:性能与质量评估。国际临床化学和检验医学联合会科学部,分子生物学技术委员会。
Clin Chem. 1997 Jul;43(7):1114-28.
2
Methods for detection of point mutations: performance and quality assessment. The IFCC Scientific Division, Committee on Molecular Biology Techniques.点突变检测方法:性能与质量评估。国际临床化学与检验医学联合会科学部,分子生物学技术委员会。
J Int Fed Clin Chem. 1997 Dec;9(4):162-70.
3
Enrichment of mutant alleles by chromatographic removal of wild type alleles: a new principle for the detection of alleles with unknown point mutations at excess of wild type alleles.
Clin Chem Lab Med. 1999 Sep;37(9):877-81. doi: 10.1515/CCLM.1999.130.
4
Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.使用与小沟结合剂偶联的荧光DNA探针定量检测K-ras基因的突变等位基因。
Int J Oncol. 2004 Mar;24(3):687-96.
5
Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. The IFCC Scientific Division: Committee on Molecular Biology Techniques.
J Int Fed Clin Chem. 1997 Dec;9(4):156-61.
6
Detection of point mutations in DNA using capillary electrophoresis in a polymer network.利用聚合物网络中的毛细管电泳检测DNA中的点突变。
J Chromatogr. 1993 Nov 24;621(2):149-56. doi: 10.1016/0378-4347(93)80090-q.
7
High-throughput single-strand conformation polymorphism analysis by automated capillary electrophoresis: robust multiplex analysis and pattern-based identification of allelic variants.通过自动毛细管电泳进行高通量单链构象多态性分析:强大的多重分析及基于模式的等位基因变异体鉴定
Hum Mutat. 1999;13(4):318-27. doi: 10.1002/(SICI)1098-1004(1999)13:4<318::AID-HUMU9>3.0.CO;2-F.
8
A quantitative assay for assessing allelic proportions by iterative gap ligation.一种通过迭代缺口连接评估等位基因比例的定量测定法。
Nucleic Acids Res. 1998 Feb 15;26(4):961-6. doi: 10.1093/nar/26.4.961.
9
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
Clin Chem Lab Med. 2005;43(8):862-8. doi: 10.1515/CCLM.2005.145.
10
K-ras point mutations in routinely processed tissues: non-radioactive screening by single strand conformational polymorphism analysis.常规处理组织中的K-ras点突变:通过单链构象多态性分析进行非放射性筛查。
J Clin Pathol. 1993 Jul;46(7):621-3. doi: 10.1136/jcp.46.7.621.

引用本文的文献

1
Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies.癌症样本和液体活检测序中基因突变的酶学法检测。
Int J Mol Sci. 2023 Jan 4;24(2):923. doi: 10.3390/ijms24020923.
2
Molecularly resolved, label-free nucleic acid sensing at solid-liquid interface using non-ionic DNA analogues.利用非离子型DNA类似物在固液界面进行分子分辨的无标记核酸传感。
RSC Adv. 2022 Mar 24;12(15):9263-9274. doi: 10.1039/d2ra00386d. eCollection 2022 Mar 21.
3
A rapid identification technique for drug-resistant isolates using mismatch specific cleavage enzyme.
一种使用错配特异性切割酶的耐药菌株快速鉴定技术。
Bioinformation. 2018 Jul 31;14(7):404-407. doi: 10.6026/97320630014404. eCollection 2018.
4
BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma.BRAF 癌基因诱导的衰老与促甲状腺激素信号在甲状腺乳头状癌进展中的作用。
Horm Cancer. 2018 Feb;9(1):1-11. doi: 10.1007/s12672-017-0315-4. Epub 2017 Dec 5.
5
The Predictive Value of Genetic Analyses in the Diagnosis of Tetrahydrobiopterin (BH4)-Responsiveness in Chinese Phenylalanine Hydroxylase Deficiency Patients.遗传分析在诊断中国苯丙氨酸羟化酶缺乏症患者四氢生物蝶呤(BH4)反应性中的预测价值。
Sci Rep. 2017 Jul 28;7(1):6762. doi: 10.1038/s41598-017-06462-y.
6
Values of molecular markers in the differential diagnosis of thyroid abnormalities.分子标志物在甲状腺异常鉴别诊断中的价值。
J Cancer Res Clin Oncol. 2017 Jun;143(6):913-931. doi: 10.1007/s00432-016-2319-9. Epub 2016 Dec 22.
7
Prevalence and Prognostic Impact of CEBPA Gene Mutation (Simplified Assay Technique) in Egyptian Acute Myeloid Leukemia Patients with Normal Cytogenetics.CEBPA基因突变(简化检测技术)在埃及细胞遗传学正常的急性髓系白血病患者中的患病率及预后影响
Indian J Hematol Blood Transfus. 2016 Dec;32(4):405-411. doi: 10.1007/s12288-015-0623-1. Epub 2015 Nov 30.
8
Hybridization-Induced Aggregation Technology for Practical Clinical Testing: KRAS Mutation Detection in Lung and Colorectal Tumors.用于实际临床检测的杂交诱导聚集技术:肺癌和结直肠癌中KRAS突变检测
J Mol Diagn. 2016 Jul;18(4):546-53. doi: 10.1016/j.jmoldx.2016.02.004. Epub 2016 Jun 8.
9
Development of low-density oligonucleotide microarrays for detecting mutations causing Wilson's disease.用于检测导致威尔逊氏病的突变的低密度寡核苷酸微阵列的开发。
Indian J Med Res. 2015 Feb;141(2):175-86. doi: 10.4103/0971-5916.155548.
10
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.靶向二代测序可识别黑色素瘤患者中具有临床可操作性的突变。
Pigment Cell Melanoma Res. 2014 Jul;27(4):653-63. doi: 10.1111/pcmr.12238. Epub 2014 Apr 7.